drugset / Trial / NCT00672061
Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety of ramelteon, once daily (QD), in individuals with obstructive sleep apnea.
Timeline
- Start
- 2003-07
- Primary completion
- 2003-12
- Completion
- 2003-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 16 mg | Oral |